Literature DB >> 22761385

Virion-associated complement regulator CD55 is more potent than CD46 in mediating resistance of mumps virus and vesicular stomatitis virus to neutralization.

John B Johnson1, Douglas S Lyles, Martha A Alexander-Miller, Griffith D Parks.   

Abstract

Enveloped viruses can incorporate host cell membrane proteins during the budding process. Here we demonstrate that mumps virus (MuV) and vesicular stomatitis virus (VSV) assemble to include CD46 and CD55, two host cell regulators which inhibit propagation of complement pathways through distinct mechanisms. Using viruses which incorporated CD46 alone, CD55 alone, or both CD46 and CD55, we have tested the relative contribution of these regulators in resistance to complement-mediated neutralization. Virion-associated CD46 and CD55 were biologically active, with VSV showing higher levels of activity of both cofactors, which promoted factor I-mediated cleavage of C3b into iC3b as well as decay-accelerating factor (DAF) activity against the C3 convertase, than MuV. Time courses of in vitro neutralization with normal human serum (NHS) showed that both regulators could delay neutralization, but viruses containing CD46 alone were neutralized faster and more completely than viruses containing CD55 alone. A dominant inhibitory role for CD55 was most evident for VSV, where virus containing CD55 alone was not substantially different in neutralization kinetics from virus harboring both regulators. Electron microscopy showed that VSV neutralization proceeded through virion aggregation followed by lysis, with virion-associated CD55 providing a delay in both aggregation and lysis more substantial than that conferred by CD46. Our results demonstrate the functional significance of incorporation of host cell factors during virion envelope assembly. They also define pathways of virus complement-mediated neutralization and suggest the design of more effective viral vectors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761385      PMCID: PMC3446622          DOI: 10.1128/JVI.01154-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Identification of complement regulatory domains in vaccinia virus complement control protein.

Authors:  Jayati Mullick; John Bernet; Yogesh Panse; Sharanabasava Hallihosur; Akhilesh K Singh; Arvind Sahu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 2.  Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster.

Authors:  M K Liszewski; T W Post; J P Atkinson
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

Review 3.  Involvement of antibody, complement and cellular immunity in the pathogenesis of enhanced respiratory syncytial virus disease.

Authors:  M Florencia Delgado; Fernando P Polack
Journal:  Expert Rev Vaccines       Date:  2004-12       Impact factor: 5.217

4.  Pseudotypes of vesicular stomatitis virus with CD4 formed by clustering of membrane microdomains during budding.

Authors:  Erica L Brown; Douglas S Lyles
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Complement regulatory proteins are incorporated into lentiviral vectors and protect particles against complement inactivation.

Authors:  C Schauber-Plewa; A Simmons; M J Tuerk; C D Pacheco; G Veres
Journal:  Gene Ther       Date:  2005-02       Impact factor: 5.250

6.  Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.

Authors:  M Saifuddin; T Hedayati; J P Atkinson; M H Holguin; C J Parker; G T Spear
Journal:  J Gen Virol       Date:  1997-08       Impact factor: 3.891

7.  Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.

Authors:  A Vanderplasschen; E Mathew; M Hollinshead; R B Sim; G L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

8.  Measles virus receptor properties are shared by several CD46 isoforms differing in extracellular regions and cytoplasmic tails.

Authors:  D Gerlier; B Loveland; G Varior-Krishnan; B Thorley; I F McKenzie; C Rabourdin-Combe
Journal:  J Gen Virol       Date:  1994-09       Impact factor: 3.891

9.  Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype.

Authors:  T W Post; M K Liszewski; E M Adams; I Tedja; E A Miller; J P Atkinson
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

10.  Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).

Authors:  H Stoiber; C Pintér; A G Siccardi; A Clivio; M P Dierich
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  16 in total

1.  Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method.

Authors:  Donald R Latner; Marcia McGrew; Nobia J Williams; Sun B Sowers; William J Bellini; Carole J Hickman
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

Review 2.  Interactions of viruses and the humoral innate immune response.

Authors:  Bailey E Maloney; Krishani Dinali Perera; Danielle R D Saunders; Naemi Shadipeni; Sherry D Fleming
Journal:  Clin Immunol       Date:  2020-02-04       Impact factor: 3.969

Review 3.  Paramyxovirus activation and inhibition of innate immune responses.

Authors:  Griffith D Parks; Martha A Alexander-Miller
Journal:  J Mol Biol       Date:  2013-09-20       Impact factor: 5.469

4.  CD59 association with infectious bronchitis virus particles protects against antibody-dependent complement-mediated lysis.

Authors:  Yanquan Wei; Yanhong Ji; Huichen Guo; Xiaoying Zhi; Shichong Han; Yun Zhang; Yuan Gao; Yanyan Chang; Dan Yan; Kangyu Li; Ding Xiang Liu; Shiqi Sun
Journal:  J Gen Virol       Date:  2017-10-25       Impact factor: 3.891

5.  A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b.

Authors:  John B Johnson; Viktoriya Borisevich; Barry Rockx; Griffith D Parks
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

6.  Complement-Mediated Neutralization of a Potent Neurotropic Human Pathogen, Chandipura Virus, Is Dependent on C1q.

Authors:  Umerali Kunnakkadan; Joydeep Nag; Nisha Asok Kumar; Reshma Koolaparambil Mukesh; Sreenath Muraleedharan Suma; John Bernet Johnson
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

7.  Parainfluenza virus 5 upregulates CD55 expression to produce virions with enhanced resistance to complement-mediated neutralization.

Authors:  Yujia Li; John B Johnson; Griffith D Parks
Journal:  Virology       Date:  2016-08-06       Impact factor: 3.616

8.  The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green Monkeys is dependent on complement.

Authors:  Anne E Mayer; John B Johnson; Griffith D Parks
Journal:  Virology       Date:  2014-05-29       Impact factor: 3.616

9.  Point mutations in the paramyxovirus F protein that enhance fusion activity shift the mechanism of complement-mediated virus neutralization.

Authors:  John B Johnson; Anthony P Schmitt; Griffith D Parks
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

10.  Complete study demonstrating the absence of rhabdovirus in a distinct Sf9 cell line.

Authors:  Yoshifumi Hashimoto; Daniel Macri; Indresh Srivastava; Clifton McPherson; Rachael Felberbaum; Penny Post; Manon Cox
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.